Mark S. Forman - 13 Jun 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Medical Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
13 Jun 2022
Transactions value $
$0
Form type
4
Filing time
15 Jun 2022, 17:24:49
Previous filing
20 Apr 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +136K $0.00 136K 13 Jun 2022 Common Stock 136K $2.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.